Comparative Study on Two Post-operative Adjuvant Chemotherapy Regimens for Treating Triple-negative Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: 5-Fu/epirubicin/CTX following Docetaxel|DRUG: Docetaxel/capecitabine followed by XEC
Sponsor: China Breast Cancer Clinical Study Group